RETATRUTIDE 10mg – Pharmaqo Labs

Pharmaqo proudly introduces Retatrutide 10mg—a cutting-edge, research-grade peptide at the forefront of obesity and metabolic disorder studies. Engineered as a triple-receptor agonist, Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, delivering a synergistic effect on metabolic regulation, appetite suppression, insulin activity, and fat utilization.